
{{Infobox United States federal proposed legislation
| name = Prostate Research, Outreach, Screening, Testing, Access, and Treatment Effectiveness Act of 2013
| fullname        = To reduce disparities and improve access to effective and cost efficient diagnosis and treatment of prostate cancer through advances in testing, research, and education, including through telehealth, comparative effectiveness research, and identification of best practices in patient education and outreach particularly with respect to underserved racial, ethnic and rural populations and men with a family history of prostate cancer, to establish a directive on what constitutes clinically appropriate prostate cancer imaging, and to create a prostate cancer scientific advisory board for the Office of the Chief Scientist at the Food and Drug Administration to accelerate real-time sharing of the latest research and accelerate movement of new medicines to patients.
| acronym         =
| nickname        =
| introduced in the = 113th
| introduceddate   =
| sponsored by    = [[Jon_Tester|Sen. Jon Tester (D, MT)]]
| number of co-sponsors = 1
| public law url  =
| cite public law =
| cite statutes at large =
| acts affected = [[Prostate Research, Outreach, Screeening, Testing, Access, and Treatment Effectiveness Act of 2013]], [[Federal Advisory Committee Act]], [[Medicare Improvements for Patients and Providers Act of 2008]], [[Resource Utilization Report]], [[Public Health Service Act]], and others.
| acts repealed   =
| title affected   =
| sections created =
| sections affected = {{USC|5}}
| agenciesaffected = [[National Institutes of Health]], [[Agency for Healthcare Research and Quality]], [[Health Resources and Services Administration]], [[United States Department of Veterans Affairs]], [[Centers for Disease Control and Prevention]], [[Centers for Medicare and Medicaid Services]], [[United States Congress]], [[Department of Health and Human Services]], [[United States Department of Defense]], [[Food and Drug Administration]]
| authorizationsofappropriations = an unlimited amount for each of fiscal years 2014, 2015, 2016, 2017 and 2018
| appropriations =
| leghisturl      =
| introducedin    = Senate
| introducedbill  = {{USBill|113|s|516}}
| introducedby    = [[Jon_Tester|Sen. Jon Tester (D, MT)]]
| introduceddate  = March 11, 2013
| committees      = [[United States Senate Committee on Health, Education, Labor, and Pensions]]
| passedbody1     =
| passeddate1     =
| passedvote1     =
| passedbody2     =
| passedas2       =
| passeddate2     =
| passedvote2     =
| conferencedate  =
| passedbody3     =
| passeddate3     =
| passedvote3     =
| agreedbody3     =
| agreeddate3     =
| agreedvote3     =
| agreedbody4     =
| agreeddate4     =
| agreedvote4     =
| passedbody4     =
| passeddate4     =
| passedvote4     =
| signedpresident =
| signeddate      =
| unsignedpresident =
| unsigneddate    =
| vetoedpresident =
| vetoeddate      =
| overriddenbody1 =
| overriddendate1 =
| overriddenvote1 =
| overriddenbody2 =
| overriddendate2 =
| overriddenvote2 =
| amendments      =
| SCOTUS cases    =
}}
++++++++++++++++++++++++++++++


authorizationsofappropriations :
indefinite for each of fiscal years 2014, 2015, 2016, 2017 and 2018


Acts impacted, by reference count:
	9:	Prostate Research, Outreach, Screeening, Testing, Access, and Treatment Effectiveness Act of 2013
	2:	Federal Advisory Committee Act
	1:	Medicare Improvements for Patients and Providers Act of 2008
	1:	Resource Utilization Report
	1:	Public Health Service Act


Sections impacted, by reference count:
	1:	{{USC|5}}


Proposed agencies (not listed above):
	"Interagency Prostate Cancer Coordination and Education Task Force" was proposed

-30-